CATALOGO DEI PRODOTTI DELLA RICERCA

GIACOPUZZI, Simone
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.133
EU - Europa 5.835
AS - Asia 4.210
SA - Sud America 602
AF - Africa 215
Continente sconosciuto - Info sul continente non disponibili 199
OC - Oceania 19
Totale 18.213
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.854
RU - Federazione Russa 2.502
SG - Singapore 1.675
CN - Cina 1.147
GB - Regno Unito 1.001
IT - Italia 853
BR - Brasile 472
VN - Vietnam 408
HK - Hong Kong 311
DE - Germania 273
SE - Svezia 257
IE - Irlanda 256
FR - Francia 218
FI - Finlandia 164
KR - Corea 148
CA - Canada 142
BD - Bangladesh 124
JP - Giappone 67
IN - India 64
UA - Ucraina 61
TR - Turchia 59
NL - Olanda 48
ES - Italia 45
AR - Argentina 42
NG - Nigeria 39
ZA - Sudafrica 36
TG - Togo 33
ID - Indonesia 31
IL - Israele 29
MX - Messico 29
AT - Austria 28
BJ - Benin 27
PL - Polonia 27
IQ - Iraq 26
CO - Colombia 22
CR - Costa Rica 21
SC - Seychelles 19
AU - Australia 18
LT - Lituania 17
UZ - Uzbekistan 16
TT - Trinidad e Tobago 14
CL - Cile 13
EC - Ecuador 13
HN - Honduras 13
MA - Marocco 13
PK - Pakistan 13
AE - Emirati Arabi Uniti 12
BE - Belgio 12
VE - Venezuela 12
GT - Guatemala 11
JM - Giamaica 11
PY - Paraguay 11
GR - Grecia 10
NO - Norvegia 10
SA - Arabia Saudita 10
DZ - Algeria 9
EG - Egitto 9
IR - Iran 9
KE - Kenya 9
CZ - Repubblica Ceca 8
NI - Nicaragua 8
SV - El Salvador 8
PE - Perù 7
PH - Filippine 7
UY - Uruguay 7
AL - Albania 6
JO - Giordania 6
KZ - Kazakistan 6
MY - Malesia 6
PT - Portogallo 6
EU - Europa 5
LB - Libano 5
SI - Slovenia 5
AO - Angola 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
HU - Ungheria 4
KG - Kirghizistan 4
LV - Lettonia 4
OM - Oman 4
PA - Panama 4
PR - Porto Rico 4
PS - Palestinian Territory 4
BB - Barbados 3
CI - Costa d'Avorio 3
DK - Danimarca 3
LK - Sri Lanka 3
NP - Nepal 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
TW - Taiwan 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
AZ - Azerbaigian 2
BO - Bolivia 2
BY - Bielorussia 2
BZ - Belize 2
CW - ???statistics.table.value.countryCode.CW??? 2
EE - Estonia 2
Totale 17.998
Salva come PNG Salva come JPEG
Città #
Ashburn 1.120
Singapore 893
Moscow 804
Southend 796
San Jose 743
Dallas 550
Chandler 486
Hong Kong 302
Verona 296
Jacksonville 264
Dublin 255
New York 238
Council Bluffs 234
Beijing 219
The Dalles 190
Woodbridge 184
Ho Chi Minh City 147
Los Angeles 143
Ann Arbor 123
Hanoi 87
Santa Clara 80
Jinan 76
Lawrence 73
Princeton 73
Milan 71
Munich 70
Wilmington 70
Helsinki 64
Houston 62
Tokyo 59
Redmond 57
Nanjing 55
Buffalo 50
São Paulo 50
London 47
Shenyang 46
Atlanta 45
Hebei 40
Rome 40
Seoul 39
Abuja 38
Orem 38
Montreal 35
Redondo Beach 35
Brooklyn 33
Lomé 33
North Bergen 33
Changsha 32
Columbus 31
Denver 30
Guangzhou 30
Seattle 30
Sindelfingen 30
Tianjin 29
Zhengzhou 29
Amsterdam 27
Cotonou 27
Frankfurt am Main 27
Phoenix 26
Dong Ket 24
San Francisco 24
McKinney 23
Warsaw 23
Washington 23
Haikou 22
Madrid 22
Chicago 21
Johannesburg 21
Toronto 21
Chennai 20
Hangzhou 20
Manchester 19
Nanchang 19
Turku 19
Vienna 19
Ankara 18
Lappeenranta 18
Stockholm 18
Bologna 17
San José 17
Jiaxing 16
Naples 16
Taizhou 16
Ningbo 15
Rio de Janeiro 15
Boston 14
Nuremberg 14
Poplar 14
Shanghai 14
Taiyuan 14
Tombolo 14
Baghdad 13
Belo Horizonte 13
Boardman 13
Charlotte 13
Jakarta 13
Redwood City 13
Tashkent 13
Da Nang 12
Mumbai 12
Totale 10.539
Salva come PNG Salva come JPEG
Nome #
An FGFR3 autocrine loop sustains acquired resistance to trastuzumab in gastric cancer patients 329
Anastomotic leak following oesophagectomy: research priorities from an international Delphi consensus study 316
Extranodal extension of lymph node metastasis is a marker of poor prognosis in oesophageal cancer: a systematic review with meta-analysis 308
[Preliminary results of neoadjuvant treatment of adenocarcinoma of the gastro-esophageal junction]. 288
Pediatric Palliative Care: Historical Origins and a Glimpse into Ethical Issues 270
L’ espressione di BIRC3 come predittore di resistenza alla chemioradioterapia neoadiuvante nell’adenocarcinoma del cardias e nel carcinoma squamoso dell’esofago 242
Pretreatment Primary Tumor Stage is a Risk Factor for Recurrence in Patients with Esophageal Squamous Cell Carcinoma Who Achieve Pathological Complete Response After Neoadjuvant Chemoradiotherapy 222
Impact of super-extended lymphadenectomy on relapse in advanced gastric cancer. 219
A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal-gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trial 218
Adenocarcinoma of the esophagogastric junction 217
Outcomes after Surgical Treatment of Oesophagogastric Cancer with Synchronous Liver Metastases: A Multicentre Retrospective Cohort Study 216
ypN0: Does It Matter How You Get There? Nodal Downstaging in Esophageal Cancer 213
The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015 209
Textbook outcome following oesophagectomy for cancer: international cohort study 205
Thoracic Aortic Pseudoaneurysm after Esophageal Perforation and Mediastinitis Caused by Accidental Ingestion of a Mutton Bone: A Case Report on Staged Endoscopic and Endovascular Treatments 204
Siewert III esophagogastric junction adenocarcinoma: does TNM 8th save us? 200
ASO Author Reflections: Recurrence After Pathological Complete Response in Esophageal Cancer: Analysis of Risk Factors for this Unexpected Event 198
Changing clinical and pathological features of gastric cancer over time. 195
Enhanced recovery after surgery protocol in patients undergoing esophagectomy for cancer: a single center experience 195
Acute bleeding obstruction pancreatitis after Roux-en-Y anastomosis in total gastrectomy: a single center experience 195
Targeted therapies for advanced and metastatic adenocarcinoma of the gastroesophageal junction: is there something new? 191
Response to induction therapy in oesophageal and cardia carcinoma using Mandard tumour regression grade or size of residual foci 188
A national survey on the current status of minimally invasive gastric practice on behalf of GIRCG 184
TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients 182
Is there any role for super-extended limphadenectomy in advanced gastric cancer? results of an observational study from a western high volume center 181
Effectiveness of endoscopic vacuum therapy as rescue treatment in refractory leaks after gastro-esophageal surgery 178
18F-FDG PET/CT Metrics Are Correlated to the Pathological Response in Esophageal Cancer Patients Treated With Induction Chemotherapy Followed by Neoadjuvant Chemo-Radiotherapy 177
Chemoradiotherapy followed by surgery for squamous cell carcinoma of the thoracic esophagus with clinical evidence of adjacent organ invasion. 176
Neoadjuvant Concurrent Chemoradiotherapy for Locally Advanced Esophageal Cancer in a Single High-Volume Center. 175
Long-Term Outcomes of Induction Chemotherapy Followed by Chemo-Radiotherapy as Intensive Neoadjuvant Protocol in Patients with Esophageal Cancer 172
Bidirectional Approach with PIPAC and Systemic Chemotherapy for Patients with Synchronous Gastric Cancer Peritoneal Metastases (GCPM) 170
Current practice on the use of prophylactic drain after gastrectomy in Italy: the Abdominal Drain in Gastrectomy (ADiGe) survey 170
Tumor Site and Perigastric Nodal Status are the Most Important Predictors of Para-Aortic Nodal Involvement in Advanced Gastric Cancer 170
Feasibility and safety of an enhanced recovery protocol (ERP) for upper GI surgery in elderly patients (≥ 75 years) in a high-volume surgical center 169
Active surveillance for clinical complete responders after chemoradiotherapy for oesophageal squamous cell carcinoma 168
Tailored treatment for signet ring cell gastric cancer 166
Complications after gastrectomy for cancer: Italian perspective 164
Gastric conduit perforation after Ivor Lewis esophagectomy successfully treated with endoscopic vacuum therapy (E-VAC): a case report 164
Comparison of short-term outcomes from the International Oesophago-Gastric Anastomosis Audit (OGAA), the Esophagectomy Complications Consensus Group (ECCG), and the Dutch Upper Gastrointestinal Cancer Audit (DUCA) 162
Gastric stump cancer after distal gastrectomy for benign disease: clinicopathological features and surgical outcomes. 162
Surgical treatment of gastric cancer with coexistent abdominal aortic aneurysm. Personal experience and literature review 160
Multicenter Study of Presentation, Management, and Postoperative and Long-Term Outcomes of Septegenerians and Octogenerians Undergoing Gastrectomy for Gastric Cancer 160
Adenocarcinoma of the esophagogastric junction; going up or down? 160
Nodal Staging in Adenocarcinoma of the Gastro-Esophageal Junction. Proposal of a Specific Staging System. Ann Surg Oncol. 159
Western strategy for EGJ carcinoma 159
Lymphadenectomy: how to do it? 159
Genetic prediction of long-term survival after neoadjuvant chemoradiation in locally advanced esophageal cancer 158
Incidence and Prognostic Value of Metastases to "Posterior" and Para-aortic Lymph Nodes in Resectable Gastric Cancer 158
Effect of Pyloroplasty on Gastric Conduit Emptying and Patients' Quality of Life After Ivor Lewis Esophagectomy 158
Comparison of outcomes of multiple platforms for assisted robotic-prostatectomy: rationale and design 158
Perianastomotic drainage in Ivor-Lewis esophagectomy, does habit affect utility? An 11-year single-center experience 157
Preliminary Experience with Prophylactic Thoracic Endovascular Aortic Repair in Patients Affected by Advanced Esophageal Cancer 157
ASO Visual Abstract: Bidirectional Approach with PIPAC and Systemic Chemotherapy for Patients with Synchronous Gastric Cancer Peritoneal Metastases (GCPM) 155
Proximal Gastrectomy: Technical Notes 155
Lymph node involvement in advanced gastroesophageal junction adenocarcinoma 155
Utility of Abdominal Drain in Gastrectomy (ADiGe) Trial: study protocol for a multicenter non-inferiority randomized trial 155
The amount of cells with Signet Ring Cell morphology has a prognostic impact in poorly cohesive gastric carcinoma 154
Robotic versus open Ivor-Lewis esophagectomy: A more accurate lymph node dissection without burdening the leak rate 149
Evaluation of Siewert classification in gastro-esophageal junction adenocarcinoma: What is the role of endoscopic ultrasonography? 149
International consensus on a complications list after gastrectomy for cancer 149
Clinical predictors of postoperative complications in the context of enhanced recovery (ERAS) in patients with esophageal and gastric cancer 148
Esophageal surgery in Italy. Criteria to identify the hospital units and the tertiary referral centers entitled to perform it 146
Laparoscopic transhiatal suture and gastric valve as a safe and feasible treatment for Boerhaave's syndrome: an Italian single center case series study 145
Robotic-assisted surgical staging with sentinel node biopsy for apparently early-stage endometrial cancer using the modular multi-arm surgical robot system Versius® (Cambridge Medical Robots): a case series 144
Super-extended (D3) lymphadenectomy in advanced gastric cancer . 144
Limited Usefulness of 18F-FDG PET/CT in Predicting Tumor Regression After Preoperative Chemotherapy for Noncardia Gastric Cancer: The Italian Research Group for Gastric Cancer (GIRCG) Experience 141
Surgical treatment of gasto-esophageal junction adenocarcinoma: long-term results of a single Italian centre 140
Mortality from esophagectomy for esophageal cancer across low, middle, and high-income countries: An international cohort study 139
Significance of super-extended (D3) lymphadenectomy in gastric cancer surgery 139
Para-aortic lymphadenectomy in surgery for gastric cancer: current indications and future perspectives 136
The "Weekday Effect" on Enhanced Recovery after Surgery Protocol for Gastrectomy 132
Metachronous hepatic metastases from gastric carcinoma: a multicentric survey. 132
Severe necrotic and septic pancreatitis. Indications to endoscopic surgical and nutritional therapy 132
Treatment of esophago-gastric junction adenocarcinoma 132
Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer 131
Indexes of surgical quality in gastric cancer surgery: experience of an Italian network 129
Incidence and Grading of Complications After Gastrectomy for Cancer Using the GASTRODATA Registry: A European Retrospective Observational Study 128
External Validation of a Score Predictive of Recurrence after Radical Surgery for Non-Cardia Gastric Cancer: Results of a Follow-Up Study 126
Long term results of ajuvant treatment in epidermoid carcinoma of the thoracic esophagus 125
Turning left or right? A comparative analysis in adenocarcinomas of the esophagogastric junction according to the seventh AJCC TNM classification for cancers of the esophagus and stomach: experience in a Chinese single institution 125
Reconstruction Techniques and Associated Morbidity in Minimally Invasive Gastrectomy for Cancer: Insights From the GastroBenchmark and GASTRODATA databases 123
Prosthetic voice rehabilitation after laryngoesophagectomy: surgical and functional outcomes 123
Long-Term Results with Surgery Alone and Multimodal Treatments 123
Recurrence in node-negative advanced gastric cancer: Novel findings from an in-depth pathological analysis of prognostic factors from a multicentric series 123
Is a robot surgeon with AI the ideal surgeon? A philosophical analysis 120
Major vessel resection for complete cytoreduction in primary advanced and recurrent ovarian malignancies: A case series and systematic review of the literature - pushing the boundaries in oncovascular surgery 119
Risultati preliminari del trattamento neoadiuvante dell’adenocarcinoma del giunto esofago-gastrico. 117
Gastric Cancer Maximum Tumour Diameter Reduction Rate at CT Examination as a Radiological Index for Predicting Histopathological Regression after Neoadjuvant Treatment: A Multicentre GIRCG Study 117
Treatment of EGJ Cancer within or outside clinical trials: Does the setting matter? A monocentric prospective observational study 116
Clinical outcomes of patients with complicated post-operative course after gastrectomy for cancer: a GIRCG study using the GASTRODATA registry 116
Preliminary results of neoadjuvant treatment of adenocarcinoma of the gastro-esophageal. 116
MULTICENTER STUDY ON THE INCIDENCE AND TREATMENT OF MEDIASTINAL LEAKS AFTER ESOPHAGECTOMY (MUMELE 2) 114
Transthoracic esophagectomy compared to transhiatal extended gastrectomy for adenocarcinoma of the esophagogastric junction: a multicenter retrospective cohort study 113
Open versus laparoscopic gastrectomy for advanced gastric cancer: a propensity score matching analysis of survival in a western population-on behalf of the Italian Research Group for Gastric Cancer 110
Does Pathological Stage and Nodal Involvement Influence Long Term Oncological Outcomes after CROSS Regimen for Adenocarcinoma of the Esophagogastric Junction? A Multicenter Retrospective Analysis 109
Cutoff values of major surgical complications rates after gastrectomy 109
Management, short and long-term outcomes in septegenerians and octegenerians undergoing gastrectomy for cancer 108
Follow-up after gastrectomy for cancer. An appraisal of the Italian Research Group for Gastric Cancer 108
Impact of COVID-19 outbreak on esophageal cancer surgery in Northern Italy: lessons learned from a multicentric snapshot 107
Perioperative Outcomes in Open Versus Minimally Invasive Gastrectomy For Gastric Cancer: A European Multicenter Study Based on the GASTRODATA Registry 102
Totale 16.259
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.688
article - articoli 63.226
book - libri 611
conference - conferenze 595
curatela - curatele 0
other - altro 563
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.693
Totale 133.376
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022316 0 0 0 0 27 25 8 40 15 20 31 150
2022/20231.461 82 152 133 217 115 373 5 105 179 17 32 51
2023/20241.025 25 70 75 112 90 205 48 61 24 69 190 56
2024/20252.677 123 143 142 418 145 154 203 132 343 216 200 458
2025/20268.078 494 381 490 1.394 2.118 537 758 450 579 457 219 201
2026/20271.861 119 275 280 1.014 173 0 0 0 0 0 0 0
Totale 18.213